Letters from FDA underscore heated rivalry

11/8/2012 | Pharmalot.com

The FDA Office of Prescription Drug Promotion issued in October untitled letters to Cornerstone Therapeutics and ONY Pharmaceuticals for promoting their respective drugs for neonatal respiratory disease syndrome. The two drugmakers are cited by the FDA for making unsupported superiority claims and omitting risk information. The letters are a sign of what can happen when drugs are marketed at the expense of rivals, according to this article.

View Full Article in:

Pharmalot.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Assistant General Counsel
Cardinal Health
Columbus, OH
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC